期刊文献+

Ibutilide decreases defibrillation threshold by the reduction of activation pattern complexity during ventricular fibrillation in canine hearts 被引量:1

Ibutilide decreases defibrillation threshold by the reduction of activation pattern complexity during ventricular fibrillation in canine hearts
原文传递
导出
摘要 Background Ibutilide has been commonly used for pharmacologic cardioversion of atrial fibrillation and flutter in clinical settings. The objective of this study was to investigate the effects of ibutilide on the defibrillation threshold (DFT), restitution properties, dispersion of refractoriness and activation patterns during ventricular fibrillation (VF). Methods Ibutilide was administrated intravenously in six open-chest beagles. Before and after the drug administration, 20-second episodes of VF were electrically induced and recorded with a 10×10 unipolar electrode plaque sutured on the lateral epicardium of the left ventricle. DFT and VF activation patterns, including type of epicardial activation maps, VF cycle length (VF-CL), conduction velocity, wavelength (WL) and reentry incidence, were measured. Restitution properties and dispersion of refractoriness were estimated from activation recovery intervals (ARI) during pacing. Results Compared to baseline, ibutilide markedly decreased the DFT by 31% ((491±14) V vs. (337±59) V, P 〈0.01). The drug significantly reduced the maximal slope of the restitution curve (1.34±0.08 vs. 0.76±0.06, P 〈0.01) and its epicardial dispersion (0.36±0.09 vs. 0.21±0.06, coefficient of variation, P=0.03). The dispersion of refractoriness was enhanced at the pacing cycle length of 300 ms to 160 ms by ibutilide. The drug significantly increased the VF-CL ((96±19) ms vs. (112±20) ms, P 〈0.01) and the WL ((41±9) mm vs. (52±14) mm, P=0.02) during VF, and reduced the reentry incidence by 25% (0.08±0.02 vs. 0.06±0.02, P 〈0.01). In the epicardial activation maps, ibutilide significantly reduced the percentage of more complex activation maps during VF. Conclusions Intravenous ibutilide significantly decreased the DFT. It might be due to reduction of activation pattern complexity during VF. Background Ibutilide has been commonly used for pharmacologic cardioversion of atrial fibrillation and flutter in clinical settings. The objective of this study was to investigate the effects of ibutilide on the defibrillation threshold (DFT), restitution properties, dispersion of refractoriness and activation patterns during ventricular fibrillation (VF). Methods Ibutilide was administrated intravenously in six open-chest beagles. Before and after the drug administration, 20-second episodes of VF were electrically induced and recorded with a 10×10 unipolar electrode plaque sutured on the lateral epicardium of the left ventricle. DFT and VF activation patterns, including type of epicardial activation maps, VF cycle length (VF-CL), conduction velocity, wavelength (WL) and reentry incidence, were measured. Restitution properties and dispersion of refractoriness were estimated from activation recovery intervals (ARI) during pacing. Results Compared to baseline, ibutilide markedly decreased the DFT by 31% ((491±14) V vs. (337±59) V, P 〈0.01). The drug significantly reduced the maximal slope of the restitution curve (1.34±0.08 vs. 0.76±0.06, P 〈0.01) and its epicardial dispersion (0.36±0.09 vs. 0.21±0.06, coefficient of variation, P=0.03). The dispersion of refractoriness was enhanced at the pacing cycle length of 300 ms to 160 ms by ibutilide. The drug significantly increased the VF-CL ((96±19) ms vs. (112±20) ms, P 〈0.01) and the WL ((41±9) mm vs. (52±14) mm, P=0.02) during VF, and reduced the reentry incidence by 25% (0.08±0.02 vs. 0.06±0.02, P 〈0.01). In the epicardial activation maps, ibutilide significantly reduced the percentage of more complex activation maps during VF. Conclusions Intravenous ibutilide significantly decreased the DFT. It might be due to reduction of activation pattern complexity during VF.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第15期2701-2707,共7页 中华医学杂志(英文版)
基金 This study was supported by grants from the National Natural Science Foundation of China (No. 81070266 and No. 81000081) Shanghai Science and Technology Committee (No. 10140903100 and No. 11ZR1422800) Program for Innovative Research Team of Shanghai Municipal Education Commission.
关键词 ventricular fibrillation defibrillation threshold restitution ibutilide ventricular fibrillation defibrillation threshold restitution, ibutilide
  • 相关文献

参考文献1

二级参考文献16

  • 1Volqman AS, Carberry PA, Stambler B, Lewis WR, Dunn GH, Perry KT, et al. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coil Cardiol 1998; 31: 1414-1419.
  • 2Vos MA, Golitsyn SR, Stangl K, Ruda MY, Van Wijk LV, Harry JD, et al. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group. Heart 1998; 79: 568-575.
  • 3Das MK, Cheriparambil K, Bedi A, Kassotis J, Reddy CV, Saul B, et al. Cardioversion of atrial fibrillation with ibutilide: when is it most effective? Clin Cardiol 2002; 25:411-415.
  • 4Giudici MC, Fischer WJ 3rd, Cervantes DC, Schrumpf PE, Paul DL, Sentman KE, et al. Ibutilide therapy for atrial fibrillation: 5-year experience in a community hospital. J Cardiovasc Nurs 2008; 23: 484-488.
  • 5Kafkas NV, Patsilinakos SP, Mertzanos GA, Papageorgiou KI, Chaveles JI, Dagadaki OK, et al. Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter. lnt J Cardiol 2007; 118: 321-325.
  • 6Korantzopoulos P, Kolettis TM, Papathanasiou A, Naka KK, Kolios P, Leontaridis I, et al. Propafenone added to ibutilide increases conversion rates of persistent atrial fibrillation. Heart 2006; 92: 631-634.
  • 7Stambler BS, Wood MA, Ellenbogen KA, Perry KT, Wakefield LK, VanderLugt JT. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Circulation 1996; 94: 1613-1621.
  • 8Buchanan LV, Kabell GG, Gibson JK. Acute intravenous conversion of canine atrial flutter: comparison of antiarrhythmic agents. J Cardiovasc Pharmacol 1995; 25: 539-544.
  • 9Cimini MG, Brunden MN, Gibson JK. Effects of ibutilide fumarate, a novel antiarrhythmic agent, and its enantiomers on isolated rabbit myocardium. Eur J Pharmacol 1992; 222: 93-98.
  • 10Lee KS. Ibutilide, a new compound with potent class III antiarrhythmic activity, activates a slow inward Na+ current in guinea pig ventricular cells. J Pharmacol Exp Ther 1992; 262: 99-108.

共引文献3

同被引文献14

  • 1韩晓东,方祖祥.心脏标测与心室颤动机制研究[J].中国心脏起搏与心电生理杂志,2004,18(6):408-413. 被引量:5
  • 2Nair M, George LK, Koshy SK. Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation [ J ]. The Journal of the American Board of Family Medicine, 2011,24 ( 1 ) :86.
  • 3Labhasetwar V, Underwood T, Heil Jr RW,et al. Epicardial admin- istration of ibutilide from polyurethane matrices : effects on defibrilla- tion threshold and electrophysiologic parameters[ J]. Journal of car- diovascular pharmacology, 1994,24 ( 5 ) : 826.
  • 4Wang Y, Hill JA. Electrophysiological remodeling in heart failure. [J]. Journal of Molecular and Cellular Cardiology, 2010,48(4) : 619.
  • 5Jacob S, Pidlaoan V, Singh J, et al. High defibrillation threshold: the science, signs and solutions[J]. Indian pacing and Eleetrephys- iology Journal,2010,10( 1 ) :21.
  • 6Sun JL, Han R, Guo JH, et al. Effect of ibutilide on the canine cardiac conduction system [ J ]. Cell Biochemistry and Biophysics, 2012,64(2) :161.
  • 7Rensma PL, Allessie MA, Lammers W, et al. Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal con- scious dogs[J]. Circ Res,1988,62(2) :395.
  • 8Tabereaux PB, Dosdall D J, Ideker RE. Mechanisms of VF mainte- nance : wandering wavelets, mother rotors, or foci [ J ]. Heart Rhythm, 2009,6 ( 3 ) :405.
  • 9Weiss JN, Chen PS, Qu Z, et al. Ventricular fibrillation: how do we stop the waves from breaking [ J ] ? Cire Res, 2000,87 ( 12 ) : 1 103.
  • 10Chen IXS, Wu TJ, Ting CT, et al. A tale of two fibrillations [ J ]. Circulation,2003,108(19) :2 298.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部